NCT03541720View on ClinicalTrials.gov

18F-Fluorodopamine PET Studies of Neuroblastoma and Pheochromocytoma

EARLY_PHASE1RecruitingINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

April 30, 2019

Primary Completion Date

January 1, 2027

Study Completion Date

July 1, 2028

Conditions
NeuroblastomaPheochromocytoma
Interventions
DRUG

18F-DA

18F-DA is an investigational PET radiotracer

Trial Locations (1)

38119

RECRUITING

St. Jude Children's Research Hospital, Memphis

All Listed Sponsors
lead

St. Jude Children's Research Hospital

OTHER